Vimta Labs Overview
Fundamentals of Vimta Labs
|P/E Ratio (TTM)||24.88|
|Debt to Equity||0.05|
Financials of Vimta Labs
|Sep 2022||Dec 2022||Mar 2023||Jun 2023|
|Profit before tax||17.76||14.08||16.55||16.3|
|EPS in Rs||5.97||4.62||5.73||5.51|
About Vimta Labs
Vimta Labs Ltd., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer go ... ods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc. The Company was awarded ISO 9002 Certification under ISO/IEC Guide-25 as Certified Competent Laboratory and Quality Endorsed Company by Standards Australia Quality Assurance Services Pty. Ltd in 1994. In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia. During 2002, the company begun to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials. The Company is now expanding its operations by five times of its existing capacities at S P Biotech Park, Genome Valley, Turkapally Village, Shamirpet Mandal, Ranga Reddy Dist. The project is expected to commence from September 2005. During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006. During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company. Read More
|Stocks||Market Cap (cr)||Market Price (₹)||52 Week Low-High (₹)|
|PTL Enterprises Ltd||₹553.34||
|41.55 - 42.7|
|Service Care Ltd||₹69.68||
|60 - 60.5|
|Madhav Marbles and Granites Ltd||₹44.28||
|49.65 - 53.9|
|Shreeoswal Seeds & Chemicals Ltd||₹548.44||
|70.1 - 73.4|
|Century Plyboards (India) Ltd||₹14,497.90||
|636.4 - 658.8|
What is the Share price of Vimta Labs (VIMTALABS)?
Can I buy Vimta Labs (VIMTALABS) shares?
How do I buy Vimta Labs (VIMTALABS) from Angel One?
- Direct investment: You can buy Vimta Labs (VIMTALABS) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Vimta Labs (VIMTALABS) shares.